Researchers reported, “Symptom relief was greatest after consumption of plant variants with slightly higher than average levels of the terpenes myrcene and terpinolene.”
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
Investigators reported reductions in patients’ agitation, apathy, irritability, sleep disturbances, and eating disturbances following cannabis treatment.
Lifetime heavy cannabis use was associated with decreased blood pressure, authors concluded.
Forty-five percent of respondents said that the marijuana industry should be less regulated than it is now.
“This is the first published study examining long-term cannabis efficacy in chronic combat treatment-resistant PTSD patients,” authors acknowledged.
Among those taking prescription medications at the onset of the study, 65% ceased their use of opioids, 60% stopped using antidepressants, and 58% ceased their use of anticonvulsants.
Cannabis therapy was associated with sustained improvements in pain, anxiety, sleep, and other health-related outcomes.
According to a new economic analysis, excise taxes from retail cannabis sales in Oklahoma could yield $434 million in new tax revenue over four years.